Cybin Reports Fiscal Year 2024 Financial Results and Recent Business Highlights
- Received U.S. Food and Drug Administration ("FDA") Breakthrough Therapy Designation ("BTD") for CYB003, its proprietary deuterated psilocybin analog in...
- Received U.S. Food and Drug Administration ("FDA") Breakthrough Therapy Designation ("BTD") for CYB003, its proprietary deuterated psilocybin analog in...
For Immediate ReleaseChicago, IL – June 24, 2024 – Today, Zacks Equity Research discusses Datadog DDOG, monday.com MNDY and Gitlab...
For Immediate ReleaseChicago, IL – June 7, 2024 – Today, Zacks Equity Research discusses Golub Capital BDC, Inc. GBDC and...
NORTHAMPTON, MA / ACCESSWIRE / March 7, 2024 / Las Vegas SandsAs part of Women's History Month 2024, Sands is...